HeartSciences Inc. (HSCS) Accumulated Expenses (2022 - 2026)

HeartSciences (HSCS) has reported Accumulated Expenses for 5 consecutive years, with $300000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Accumulated Expenses rose 68.89% year-over-year to $300000.0; the trailing twelve-month figure through Apr 2026 stood at $300000.0 (up 68.89% YoY), and the FY2026 full-year result was $300000.0, up 68.89% from the prior year.
• Accumulated Expenses rose to $300000.0 in Q2 2026 per HSCS's latest filing, from $177628.0 in the prior quarter.
• Across five years, Accumulated Expenses topped out at $1.1 million in Q2 2022 and bottomed at $177628.0 in Q2 2025.
• Historically, Accumulated Expenses has averaged $497005.8 across 5 years, with a median of $398331.0 in 2024.
• The sharpest annual moves came in 2023 and 2025: Accumulated Expenses slumped 63.38% in 2023, then jumped 81.0% in 2025.
• Over 5 years, Accumulated Expenses stood at $890654.0 in 2022, then slipped by 13.25% to $772670.0 in 2023, then sank by 52.16% to $369673.0 in 2024, then slumped by 51.95% to $177628.0 in 2025, then surged by 68.89% to $300000.0 in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $300000.0, $177628.0, and $311184.0 for Q2 2026, Q4 2025, and Q4 2025 respectively.